Predict your next investment

CONSUMER PRODUCTS & SERVICES | Veterinary Care Services

See what CB Insights has to offer

Founded Year



Acquired | Acquired



About Animal Pharmaceuticals

Animal Pharmaceuticals offers quality pet health care products including cat, horse and dog supplements and pet nutraceuticals.On September 24th, 2020, Animal Pharmaceuticals was acquired by Swedencare at a valuation of $14.33M.

Animal Pharmaceuticals Headquarter Location

3580 NW 56th Street Suite 100

Fort Lauderdale, Florida, 33309,

United States

Latest Animal Pharmaceuticals News

Global Animal Pharmaceuticals Market Research Report (2021 To 2026) - By Type, Product, Application, End-user And Region

Dec 17, 2021

Dec 17, 2021 8:15 AM EST Global Animal Pharmaceuticals Market Research Report (2021 To 2026) - By Type, Product, Application, End-user And Region DUBLIN, Dec. 17, 2021 /PRNewswire/ -- The "Animal Pharmaceuticals Market Research Report by Type, Product, Application, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets. Author: The Global Animal Pharmaceuticals Market size was estimated at USD 16.45 billion in 2020, is expected to reach USD 17.68 billion in 2021, and projected to grow at a CAGR of 7.82% reaching USD 25.84 billion by 2026. Market Statistics The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period. Competitive Strategic Window The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Company Usability Profiles The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Pharmaceuticals Market, including Aratana Therapeutics, Inc., Bayer AG, BioPredic International, Boehringer Ingelheim International GmbH, Ceva Animal Health LLC - Biomune, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Dechra Veterinary Products USA, Elanco Animal Health Inc., Eli Lilly & Company, Huvepharma, Inc., Liberty Pharma INC, Merck & Co., Inc., Perrigo Company plc, Sanofi, Sparhawk Laboratories, Vetoquinol S.A., Virbac SA, Zoetis Inc., and Zoetis, Inc. The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as:1. What is the market size and forecast of the Global Animal Pharmaceuticals Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Pharmaceuticals Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Pharmaceuticals Market?4. What is the competitive strategic window for opportunities in the Global Animal Pharmaceuticals Market?5. What are the technology trends and regulatory frameworks in the Global Animal Pharmaceuticals Market?6. What is the market share of the leading vendors in the Global Animal Pharmaceuticals Market?7. What modes and strategic moves are considered suitable for entering the Global Animal Pharmaceuticals Market? Key Topics Covered: 1. Preface 2. Research Methodology 3. Executive Summary 4. Market Overview4.1. Introduction4.2. Cumulative Impact of COVID-19 5. Market Dynamics5.1. Introduction5.2. Drivers5.2.1. Rising adoption of pets across the globe5.2.2. Increasing cases of zoonotic and chronic diseases5.2.3. Livestock population experiencing rapid growth5.2.4. Government mandatory medication and vaccination5.3. Restraints5.3.1. Several risk factors associated with animal health APIs5.4. Opportunities5.4.1. Increasing awareness and expenditure among people regarding animal healthcare5.4.2. Development of new products 5.4.3. Unmet animal needs in many countries5.5. Challenges5.5.1. Limited awareness and availability in low-income areas 6. Animal Pharmaceuticals Market, by Type6.1. Introduction6.2. Vaccine6.3. Veterinary Drugs 7. Animal Pharmaceuticals Market, by Product7.1. Introduction7.2. Anti-Inflammatories7.3. Bronchodilators7.4. Ectoparasiticides7.5. Endoparasiticides 8. Animal Pharmaceuticals Market, by Application8.1. Introduction8.2. Companion Animal8.3. Poultry 9. Animal Pharmaceuticals Market, by End-user9.1. Introduction9.2. Hospitals9.3. Laboratories9.4. Veternary Clinics 10. Americas Animal Pharmaceuticals Market10.1. Introduction10.2. Argentina10.3. Brazil10.4. Canada10.5. Mexico10.6. United States 11. Asia-Pacific Animal Pharmaceuticals Market11.1. Introduction11.2. Australia11.3. China11.4. India11.5. Indonesia11.6. Japan11.7. Malaysia11.8. Philippines11.9. Singapore11.10. South Korea11.11. Taiwan11.12. Thailand 12. Europe, Middle East & Africa Animal Pharmaceuticals Market12.1. Introduction12.2. France12.3. Germany12.4. Italy12.5. Netherlands12.6. Qatar12.7. Russia12.8. Saudi Arabia12.9. South Africa12.10. Spain12.11. United Arab Emirates12.12. United Kingdom 13. Competitive Landscape13.1. FPNV Positioning Matrix13.1.1. Quadrants13.1.2. Business Strategy13.1.3. Product Satisfaction13.2. Market Ranking Analysis13.3. Market Share Analysis, by Key Player13.4. Competitive Scenario13.4.1. Merger & Acquisition13.4.2. Agreement, Collaboration, & Partnership13.4.3. New Product Launch & Enhancement13.4.4. Investment & Funding13.4.5. Award, Recognition, & Expansion 14. Company Usability Profiles14.1. Aratana Therapeutics, Inc.14.2. Bayer AG14.3. BioPredic International14.4. Boehringer Ingelheim International GmbH14.5. Ceva Animal Health LLC - Biomune14.6. Ceva Sante Animale14.7. Dechra Pharmaceuticals PLC14.8. Dechra Veterinary Products USA14.9. Elanco Animal Health Inc.14.10. Eli Lilly & Company14.11. Huvepharma, Inc.14.12. Liberty Pharma INC14.13. Merck & Co., Inc.14.14. Perrigo Company plc14.15. Sanofi14.16. Sparhawk Laboratories14.17. Vetoquinol S.A.14.18. Virbac SA14.19. Zoetis Inc. 15. AppendixFor more information about this report visit Media Contact: Research and Markets Laura Wood, Senior Manager    For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 View original content:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.